Abstract:Objective:To investigate the serum lipoprotein associated phospholipase A2 (LP-PLA2) and nonesterified fatty acid (NEFA) level of coronary heart disease (CHD) patients,and explore the relation between the indexes and pathologic characters of CHD and postoperative prognosis of percutaneous coronary intervention (PCI).Method:According to the results of coronary angiography,the total 589 experimental subjects come from department of cardiovascular medicine were divided into four groups:189 for control subjects,117 for single-vessel disease group,126 for double-vessel disease group and 157 for multi-vessel disease group.The blood samples were collected from the venous blood of the elbow of every patients.In the meanwhile,the blood samples of 166 patients who underwent PCI surgery were collected before the surgery,6 hours after,12 hours after,24 hours after and 48 hours after the surgery,and the level of serum LP-PLA2 and NEFAlevel were detected by Automatic biochemical analyzer.The differences in serum PLP-PLA2 and NAFE level were compared between different groups of patients and patients with PCI.Results:Compared with the group of control(209.34±87.32U/L),the serum level of LP-PLA2 in the group of single-vessel disease (351.77±103.26U/L) and the group of double-vessel disease (409.14±196.34U/L) and the group of multi-vessel disease (823.65 ± 369.94 U/L) are significantly higher(P＜0.01),and the group of multi-vessel disease ＞ the group of double-vessel disease ＞ the group of single-vessel disease.The serum level of NEFA in the group of multi-vessel disease(0.92±0.49mmol/L)and the group of double-vessel disease (0.56±0.13mmol/L)and the group of single-vessel disease (1.22±0.8mmol/L) are significantly higher then the group of control subjects(0.23±0.07mmol/L)(P＜0.01).And the group of multi-vessel disease ＞ the group of double-vessel disease ＞ the group of single-vessel disease.In addition,compared with the control subjects,the serum LP-PLA2 level after the PCI surgery 6 hours (644.64±361.34U/L vs 286.12±188.32U/L,P＜0.01) is significantly higher before the surgery,and after 12 hours of the surgery(452.57±245.56U/L),and 24 hours of the surgery (385.23±132.47U/ L) and 48 hours of the surgery (325.78±144.97U/L),are continue to decrease,which is statistically significant difference compared with each other (P＜0.01).There is no significant difference of the serum level of NEFA before and after the PCI operation(P＞0.05).Conclusion:The serum levels of LP-PLA2 and NEFA are closely associated with endothelial dysfunction andvascular endothelial function and arterial wall which have important clinical significance in assessment of the lesion severity of coronary arter in CHD patients.

Lipoprotein Lipase And Premature Coronary Artery Disease

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

Relation between severe coronary stenosis lesion distribution and risk factors in young and middle-aged adults

Study on Gene Polymorphism and Activity of Lipoprotein Lipase and Its Relation to Serum Lipids in Patients with Premature Coronary Heart Disease

Relationship between plasma lipoprotein-associated phospholipase A_2 activity and coronary heart disease

Elevated Plasma Lipoprotein-Associated Phospholipase A(2) Activity is Associated with Plaque Rupture in Patients with Coronary Artery Disease

Study on Lipoprotein Lipase Polymorphism and Its Relationship with Plasm Lipids in Patients with Premature Coronary Heart Disease

Impact of Serum Levels of Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase on the Progression of Coronary Artery Disease

Association between lipoprotein-associated phospholipase A2 activity and coronary heart disease

Association of lipoprotein-associated phospholipase A 2 with characteristics of vulnerable coronary atherosclerotic plaques

Long-Term Prognostic Value of Lipoprotein(a) in Symptomatic Patients with Nonobstructive Coronary Artery Disease.

Correlation between lipoprotein-associated phospholipase A2 and main risk factors in unstable angina pectoris patients

Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention

Association Between the Lipoprotein-Associated Phospholipase A2 Activity and the Progression of Subclinical Atherosclerosis.

The Correlation Between Lipoprotein-Associated Phospholipase A2 and Severity of Coronary Artery Diseases

Correlation of Lipoprotein (a) with Clinical Stability and Severity of Coronary Artery Lesions in Patients with Coronary Artery Disease

Clinical application value of serum lipoprotein associated phospholipaseA2 in coronary atherosclerotic heart diseases

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease

Influence of remnant lipoprotein particle cholesterol on non-target lesions progression in patients undergoing percutaneous coronary intervention

The Study of the Relation between Serum Lipoprotein Associated Phospholipase A2 or Non-esterified Fatty Acid and Pathologic Characters of Coronary Artery in CHD Patients

The Correlationship of Plasma Lipoprotein-Associated Phospholipase A2, Hypersensitive C-reactive Protein and D-dimer in Coronary Artery Disease Patients